

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of MHC class I biosynthetic process (GO:0045343) | 9.59904356 |
| 2 | regulation of establishment of cell polarity (GO:2000114) | 9.22993080 |
| 3 | sex differentiation (GO:0007548) | 8.95239697 |
| 4 | stress granule assembly (GO:0034063) | 8.10839492 |
| 5 | regulation of interleukin-13 production (GO:0032656) | 7.88750992 |
| 6 | cholesterol catabolic process (GO:0006707) | 7.55374671 |
| 7 | sterol catabolic process (GO:0016127) | 7.55374671 |
| 8 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 7.28388810 |
| 9 | cerebellar Purkinje cell differentiation (GO:0021702) | 7.17480635 |
| 10 | alternative mRNA splicing, via spliceosome (GO:0000380) | 6.82621386 |
| 11 | positive regulation of vasculogenesis (GO:2001214) | 6.59394349 |
| 12 | regulation of interleukin-5 production (GO:0032674) | 6.50529802 |
| 13 | kynurenine metabolic process (GO:0070189) | 6.24544420 |
| 14 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 6.21290258 |
| 15 | ADP metabolic process (GO:0046031) | 5.92477562 |
| 16 | nucleoside diphosphate catabolic process (GO:0009134) | 5.75380538 |
| 17 | indole-containing compound catabolic process (GO:0042436) | 5.50428485 |
| 18 | indolalkylamine catabolic process (GO:0046218) | 5.50428485 |
| 19 | tryptophan catabolic process (GO:0006569) | 5.50428485 |
| 20 | centrosome duplication (GO:0051298) | 5.47133946 |
| 21 | regulation of vasculogenesis (GO:2001212) | 5.22429233 |
| 22 | regulation of metalloenzyme activity (GO:0048552) | 5.12152363 |
| 23 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.97760523 |
| 24 | lipid particle organization (GO:0034389) | 4.94375376 |
| 25 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 4.92089933 |
| 26 | synaptic vesicle maturation (GO:0016188) | 4.91131607 |
| 27 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.87747956 |
| 28 | somite rostral/caudal axis specification (GO:0032525) | 4.73195608 |
| 29 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.65081668 |
| 30 | locomotory exploration behavior (GO:0035641) | 4.61301755 |
| 31 | tryptophan metabolic process (GO:0006568) | 4.61112056 |
| 32 | bile acid biosynthetic process (GO:0006699) | 4.60187445 |
| 33 | regulation of synapse structural plasticity (GO:0051823) | 4.59764614 |
| 34 | synaptic transmission, cholinergic (GO:0007271) | 4.56202628 |
| 35 | regulation of action potential (GO:0098900) | 4.46931375 |
| 36 | positive regulation of heat generation (GO:0031652) | 4.41533248 |
| 37 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.37119126 |
| 38 | central nervous system projection neuron axonogenesis (GO:0021952) | 4.34261139 |
| 39 | vocalization behavior (GO:0071625) | 4.33189415 |
| 40 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.31528322 |
| 41 | synaptic vesicle exocytosis (GO:0016079) | 4.27752646 |
| 42 | prepulse inhibition (GO:0060134) | 4.24269877 |
| 43 | acrosome assembly (GO:0001675) | 4.20336728 |
| 44 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.11800084 |
| 45 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 4.09099513 |
| 46 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.06701979 |
| 47 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.02608079 |
| 48 | glutamate secretion (GO:0014047) | 4.01396321 |
| 49 | central nervous system neuron axonogenesis (GO:0021955) | 4.00574873 |
| 50 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.00402930 |
| 51 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.98997415 |
| 52 | cell differentiation in hindbrain (GO:0021533) | 3.97086968 |
| 53 | neurotransmitter secretion (GO:0007269) | 3.92986452 |
| 54 | behavioral response to cocaine (GO:0048148) | 3.91142311 |
| 55 | negative regulation of endothelial cell proliferation (GO:0001937) | 3.90539212 |
| 56 | seminiferous tubule development (GO:0072520) | 3.87219768 |
| 57 | synaptic transmission, dopaminergic (GO:0001963) | 3.83042402 |
| 58 | protein localization to synapse (GO:0035418) | 3.81794042 |
| 59 | response to X-ray (GO:0010165) | 3.77774267 |
| 60 | cell migration involved in gastrulation (GO:0042074) | 3.75861522 |
| 61 | protein autoprocessing (GO:0016540) | 3.75294951 |
| 62 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.69851333 |
| 63 | regulation of synaptic vesicle transport (GO:1902803) | 3.66460414 |
| 64 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.64072415 |
| 65 | striatum development (GO:0021756) | 3.63944805 |
| 66 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.63665010 |
| 67 | regulation of type 2 immune response (GO:0002828) | 3.63310760 |
| 68 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.59094869 |
| 69 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.58300019 |
| 70 | steroid catabolic process (GO:0006706) | 3.57477529 |
| 71 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.56348626 |
| 72 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.56326938 |
| 73 | regulation of gene silencing by miRNA (GO:0060964) | 3.56326938 |
| 74 | regulation of gene silencing by RNA (GO:0060966) | 3.56326938 |
| 75 | lipid translocation (GO:0034204) | 3.55465555 |
| 76 | phospholipid translocation (GO:0045332) | 3.55465555 |
| 77 | gamma-aminobutyric acid transport (GO:0015812) | 3.54970982 |
| 78 | regulation of heat generation (GO:0031650) | 3.54530225 |
| 79 | negative regulation of T cell differentiation (GO:0045581) | 3.52148015 |
| 80 | regulation of female receptivity (GO:0045924) | 3.49064264 |
| 81 | regulation of triglyceride catabolic process (GO:0010896) | 3.47033327 |
| 82 | layer formation in cerebral cortex (GO:0021819) | 3.45878882 |
| 83 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 3.45509935 |
| 84 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.45039315 |
| 85 | dopamine receptor signaling pathway (GO:0007212) | 3.44288760 |
| 86 | regulation of sequestering of triglyceride (GO:0010889) | 3.41592137 |
| 87 | indolalkylamine metabolic process (GO:0006586) | 3.40712621 |
| 88 | neuronal action potential propagation (GO:0019227) | 3.40350337 |
| 89 | positive regulation of membrane potential (GO:0045838) | 3.39037454 |
| 90 | regulation of glutamate secretion (GO:0014048) | 3.36534766 |
| 91 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.36534164 |
| 92 | exploration behavior (GO:0035640) | 3.35644170 |
| 93 | neuromuscular process controlling balance (GO:0050885) | 3.35248102 |
| 94 | negative regulation of mast cell activation (GO:0033004) | 3.35047721 |
| 95 | auditory behavior (GO:0031223) | 3.34965843 |
| 96 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.34670679 |
| 97 | positive regulation of neurotransmitter transport (GO:0051590) | 3.34028009 |
| 98 | response to amphetamine (GO:0001975) | 3.32884913 |
| 99 | activation of protein kinase A activity (GO:0034199) | 3.32660299 |
| 100 | neuron-neuron synaptic transmission (GO:0007270) | 3.32455745 |
| 101 | amine catabolic process (GO:0009310) | 3.32143555 |
| 102 | cellular biogenic amine catabolic process (GO:0042402) | 3.32143555 |
| 103 | estrogen biosynthetic process (GO:0006703) | 3.30538927 |
| 104 | regulation of superoxide metabolic process (GO:0090322) | 3.29693297 |
| 105 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.29281413 |
| 106 | dendritic spine morphogenesis (GO:0060997) | 3.27177984 |
| 107 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.26512745 |
| 108 | purine nucleoside diphosphate metabolic process (GO:0009135) | 3.26023927 |
| 109 | purine ribonucleoside diphosphate metabolic process (GO:0009179) | 3.26023927 |
| 110 | long-term memory (GO:0007616) | 3.24541979 |
| 111 | synaptic transmission, glutamatergic (GO:0035249) | 3.24320986 |
| 112 | negative regulation of dendrite development (GO:2000171) | 3.23724887 |
| 113 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.23664336 |
| 114 | CENP-A containing nucleosome assembly (GO:0034080) | 3.22638023 |
| 115 | female mating behavior (GO:0060180) | 3.21441565 |
| 116 | glutamate receptor signaling pathway (GO:0007215) | 3.20389740 |
| 117 | phosphatidylglycerol biosynthetic process (GO:0006655) | 3.18852690 |
| 118 | regulation of synaptic plasticity (GO:0048167) | 3.16737400 |
| 119 | adult walking behavior (GO:0007628) | 3.15516656 |
| 120 | response to lipoprotein particle (GO:0055094) | 3.15486741 |
| 121 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.15200345 |
| 122 | cellular potassium ion homeostasis (GO:0030007) | 3.14503209 |
| 123 | neuron cell-cell adhesion (GO:0007158) | 3.13065493 |
| 124 | NAD biosynthetic process (GO:0009435) | 3.12719353 |
| 125 | response to auditory stimulus (GO:0010996) | 3.12577566 |
| 126 | regulation of postsynaptic membrane potential (GO:0060078) | 3.12048074 |
| 127 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.11559212 |
| 128 | neurotransmitter transport (GO:0006836) | 3.08910144 |
| 129 | termination of RNA polymerase III transcription (GO:0006386) | 3.08693807 |
| 130 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.08693807 |
| 131 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.08489496 |
| 132 | adenosine receptor signaling pathway (GO:0001973) | 3.07270375 |
| 133 | negative regulation of organ growth (GO:0046621) | 3.07072978 |
| 134 | piRNA metabolic process (GO:0034587) | 3.06917019 |
| 135 | glycine transport (GO:0015816) | 3.06662772 |
| 136 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.06467578 |
| 137 | regulation of neurotransmitter levels (GO:0001505) | 3.05833045 |
| 138 | mating behavior (GO:0007617) | 3.03775603 |
| 139 | negative regulation of endothelial cell migration (GO:0010596) | 3.03738714 |
| 140 | aromatic amino acid family catabolic process (GO:0009074) | 3.01762212 |
| 141 | chromatin remodeling at centromere (GO:0031055) | 3.01426352 |
| 142 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.00110562 |
| 143 | regulation of receptor internalization (GO:0002090) | 2.98482729 |
| 144 | male meiosis I (GO:0007141) | 2.94581789 |
| 145 | regulation of G0 to G1 transition (GO:0070316) | 2.94580640 |
| 146 | regulation of phospholipid biosynthetic process (GO:0071071) | 2.94445521 |
| 147 | regulation of collateral sprouting (GO:0048670) | 2.93953342 |
| 148 | endoderm formation (GO:0001706) | 2.93708890 |
| 149 | transmission of nerve impulse (GO:0019226) | 2.92167683 |
| 150 | behavioral response to ethanol (GO:0048149) | 2.90193539 |
| 151 | detection of temperature stimulus (GO:0016048) | 2.90175482 |
| 152 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.90087354 |
| 153 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.90087354 |
| 154 | regulation of dendritic spine development (GO:0060998) | 2.89711264 |
| 155 | membrane hyperpolarization (GO:0060081) | 2.89653462 |
| 156 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.89436876 |
| 157 | L-phenylalanine catabolic process (GO:0006559) | 2.89436876 |
| 158 | metallo-sulfur cluster assembly (GO:0031163) | 2.88778478 |
| 159 | iron-sulfur cluster assembly (GO:0016226) | 2.88778478 |
| 160 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.88293914 |
| 161 | enteric nervous system development (GO:0048484) | 2.87911706 |
| 162 | neuronal ion channel clustering (GO:0045161) | 2.86980042 |
| 163 | proline transport (GO:0015824) | 2.86515073 |
| 164 | histone H3-K4 trimethylation (GO:0080182) | 2.86383383 |
| 165 | regulation of endothelial cell apoptotic process (GO:2000351) | 2.84469396 |
| 166 | neuromuscular process controlling posture (GO:0050884) | 2.83896731 |
| 167 | behavioral response to nicotine (GO:0035095) | 2.82343299 |
| 168 | one-carbon compound transport (GO:0019755) | 2.80692456 |
| 169 | neural tube formation (GO:0001841) | 2.80643190 |
| 170 | cAMP catabolic process (GO:0006198) | 2.80177266 |
| 171 | long-term synaptic potentiation (GO:0060291) | 2.79832667 |
| 172 | behavioral defense response (GO:0002209) | 2.79558287 |
| 173 | behavioral fear response (GO:0001662) | 2.79558287 |
| 174 | regulation of neurotransmitter secretion (GO:0046928) | 2.77240650 |
| 175 | regulation of neurotransmitter transport (GO:0051588) | 2.77019742 |
| 176 | L-methionine biosynthetic process (GO:0071265) | 2.75341445 |
| 177 | amino acid salvage (GO:0043102) | 2.75341445 |
| 178 | L-methionine salvage (GO:0071267) | 2.75341445 |
| 179 | peristalsis (GO:0030432) | 2.74883924 |
| 180 | negative regulation of amino acid transport (GO:0051956) | 2.74288123 |
| 181 | L-phenylalanine metabolic process (GO:0006558) | 2.73866771 |
| 182 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.73866771 |
| 183 | auditory receptor cell stereocilium organization (GO:0060088) | 2.72629661 |
| 184 | DNA demethylation (GO:0080111) | 2.71536490 |
| 185 | regulation of neurotransmitter uptake (GO:0051580) | 2.70366982 |
| 186 | membrane depolarization during action potential (GO:0086010) | 2.70166931 |
| 187 | membrane depolarization (GO:0051899) | 2.69096175 |
| 188 | vesicle transport along microtubule (GO:0047496) | 2.68584001 |
| 189 | positive regulation of synaptic transmission (GO:0050806) | 2.67831270 |
| 190 | sodium ion export (GO:0071436) | 2.67643274 |
| 191 | positive regulation of dendritic spine development (GO:0060999) | 2.66737124 |
| 192 | regulation of protein kinase A signaling (GO:0010738) | 2.66029207 |
| 193 | glutamate metabolic process (GO:0006536) | 2.65688169 |
| 194 | visual learning (GO:0008542) | 2.64818421 |
| 195 | drinking behavior (GO:0042756) | 2.64195718 |
| 196 | regulation of memory T cell differentiation (GO:0043380) | 11.7640737 |
| 197 | negative regulation of multicellular organism growth (GO:0040015) | 11.1558624 |
| 198 | cytoplasmic mRNA processing body assembly (GO:0033962) | 10.7924940 |
| 199 | negative regulation of type 2 immune response (GO:0002829) | 10.0761860 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 6.22419301 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.79337551 |
| 3 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 4.50831708 |
| 4 | VDR_22108803_ChIP-Seq_LS180_Human | 4.45528404 |
| 5 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.04481016 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.84118544 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.83742575 |
| 8 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.79448261 |
| 9 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.63858918 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.54287370 |
| 11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.54287370 |
| 12 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.50143705 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.49787832 |
| 14 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.48863184 |
| 15 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.47095485 |
| 16 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.42408453 |
| 17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.41565374 |
| 18 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.39724686 |
| 19 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.39408523 |
| 20 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.26841732 |
| 21 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.15199427 |
| 22 | ER_23166858_ChIP-Seq_MCF-7_Human | 2.14838503 |
| 23 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.13913818 |
| 24 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.13386410 |
| 25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.13363437 |
| 26 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.11973466 |
| 27 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.10065570 |
| 28 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.07849247 |
| 29 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 2.05133819 |
| 30 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.02031445 |
| 31 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.99496504 |
| 32 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.98654529 |
| 33 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.94586872 |
| 34 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.91513181 |
| 35 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.91124940 |
| 36 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.89392652 |
| 37 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.87540683 |
| 38 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.82243364 |
| 39 | FUS_26573619_Chip-Seq_HEK293_Human | 1.72742469 |
| 40 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.72183124 |
| 41 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.64547520 |
| 42 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.58827549 |
| 43 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.54224707 |
| 44 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.53974729 |
| 45 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.53231290 |
| 46 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.52342061 |
| 47 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.49446215 |
| 48 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.46785497 |
| 49 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.46285002 |
| 50 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.45666757 |
| 51 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.44457367 |
| 52 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.41468694 |
| 53 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.39247675 |
| 54 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.39161441 |
| 55 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.38711485 |
| 56 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.37670969 |
| 57 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.37474271 |
| 58 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.36463837 |
| 59 | KDM2B_26808549_Chip-Seq_REH_Human | 1.34797922 |
| 60 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.34460778 |
| 61 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.33528205 |
| 62 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.26224792 |
| 63 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.25627974 |
| 64 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.25004966 |
| 65 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.24186180 |
| 66 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.23260735 |
| 67 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.22546807 |
| 68 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.21293567 |
| 69 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.21163428 |
| 70 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.21057314 |
| 71 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.20325253 |
| 72 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.20297769 |
| 73 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.19968417 |
| 74 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.18949673 |
| 75 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.17410591 |
| 76 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.16277782 |
| 77 | KDM2B_26808549_Chip-Seq_K562_Human | 1.16171041 |
| 78 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.15956096 |
| 79 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.14723697 |
| 80 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.14269964 |
| 81 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.14071410 |
| 82 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.11980238 |
| 83 | AR_19668381_ChIP-Seq_PC3_Human | 1.11624510 |
| 84 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.10977071 |
| 85 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.10977071 |
| 86 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.10465333 |
| 87 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.10044066 |
| 88 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09809763 |
| 89 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.09691830 |
| 90 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.09413438 |
| 91 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.09061858 |
| 92 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.09061858 |
| 93 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.09039346 |
| 94 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.08720982 |
| 95 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.07970627 |
| 96 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.07542575 |
| 97 | TBL1_22424771_ChIP-Seq_293T_Human | 1.07263993 |
| 98 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.05841487 |
| 99 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.05643236 |
| 100 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.05411586 |
| 101 | P300_19829295_ChIP-Seq_ESCs_Human | 1.04403719 |
| 102 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.04145807 |
| 103 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.04137418 |
| 104 | STAT3_23295773_ChIP-Seq_U87_Human | 1.04004974 |
| 105 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.03765265 |
| 106 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.03054860 |
| 107 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.01453005 |
| 108 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01313671 |
| 109 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.00266187 |
| 110 | AR_25329375_ChIP-Seq_VCAP_Human | 0.99986290 |
| 111 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.99366171 |
| 112 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.98879359 |
| 113 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.98448497 |
| 114 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.98403027 |
| 115 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.98292441 |
| 116 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.98240593 |
| 117 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.98059513 |
| 118 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.97967819 |
| 119 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.97860983 |
| 120 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.97683138 |
| 121 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96975482 |
| 122 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.96975482 |
| 123 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96889866 |
| 124 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.96803398 |
| 125 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.96452322 |
| 126 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.94405398 |
| 127 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.94255013 |
| 128 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.93823919 |
| 129 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.93822438 |
| 130 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.93454619 |
| 131 | * TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93323889 |
| 132 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.93150338 |
| 133 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92818971 |
| 134 | NCOR_22424771_ChIP-Seq_293T_Human | 0.92643243 |
| 135 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.92355252 |
| 136 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.91789481 |
| 137 | * TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.91665141 |
| 138 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.91639978 |
| 139 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.90689180 |
| 140 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.90468453 |
| 141 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.90429005 |
| 142 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.90114689 |
| 143 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.89991255 |
| 144 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.89069502 |
| 145 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.88869518 |
| 146 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.88481613 |
| 147 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.88306284 |
| 148 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.87819445 |
| 149 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.86406170 |
| 150 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.85914391 |
| 151 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.85426354 |
| 152 | TCF4_23295773_ChIP-Seq_U87_Human | 0.84856902 |
| 153 | RXR_22108803_ChIP-Seq_LS180_Human | 0.84804769 |
| 154 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.84241636 |
| 155 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.82403431 |
| 156 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.82202366 |
| 157 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.81439336 |
| 158 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.81191636 |
| 159 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.79210824 |
| 160 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.78561217 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003011_delayed_dark_adaptation | 6.39799725 |
| 2 | MP0002822_catalepsy | 6.30397890 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 5.62988585 |
| 4 | MP0003880_abnormal_central_pattern | 3.84556561 |
| 5 | MP0000569_abnormal_digit_pigmentation | 3.74119402 |
| 6 | MP0003635_abnormal_synaptic_transmissio | 3.61413189 |
| 7 | MP0001986_abnormal_taste_sensitivity | 3.61292900 |
| 8 | MP0004270_analgesia | 3.54635119 |
| 9 | MP0009745_abnormal_behavioral_response | 3.21069200 |
| 10 | MP0002063_abnormal_learning/memory/cond | 3.03684177 |
| 11 | MP0005360_urolithiasis | 2.80769468 |
| 12 | MP0001968_abnormal_touch/_nociception | 2.71464871 |
| 13 | MP0002064_seizures | 2.71350268 |
| 14 | MP0002638_abnormal_pupillary_reflex | 2.49903980 |
| 15 | MP0002139_abnormal_hepatobiliary_system | 2.46523405 |
| 16 | MP0002572_abnormal_emotion/affect_behav | 2.42472361 |
| 17 | MP0009046_muscle_twitch | 2.40834067 |
| 18 | MP0002734_abnormal_mechanical_nocicepti | 2.35922554 |
| 19 | MP0005253_abnormal_eye_physiology | 2.35476726 |
| 20 | MP0001486_abnormal_startle_reflex | 2.34501677 |
| 21 | MP0005085_abnormal_gallbladder_physiolo | 2.31256519 |
| 22 | MP0002272_abnormal_nervous_system | 2.29024314 |
| 23 | MP0003890_abnormal_embryonic-extraembry | 2.25049772 |
| 24 | MP0000371_diluted_coat_color | 2.24060318 |
| 25 | MP0001984_abnormal_olfaction | 2.22243975 |
| 26 | MP0002736_abnormal_nociception_after | 2.03731715 |
| 27 | MP0001529_abnormal_vocalization | 1.99768900 |
| 28 | MP0005423_abnormal_somatic_nervous | 1.94685681 |
| 29 | MP0005647_abnormal_sex_gland | 1.88366427 |
| 30 | MP0001501_abnormal_sleep_pattern | 1.87410717 |
| 31 | MP0002909_abnormal_adrenal_gland | 1.86280905 |
| 32 | MP0003329_amyloid_beta_deposits | 1.85814346 |
| 33 | MP0006072_abnormal_retinal_apoptosis | 1.84861066 |
| 34 | MP0005646_abnormal_pituitary_gland | 1.82600458 |
| 35 | MP0002735_abnormal_chemical_nociception | 1.82388026 |
| 36 | MP0002733_abnormal_thermal_nociception | 1.80911142 |
| 37 | MP0003119_abnormal_digestive_system | 1.78838466 |
| 38 | MP0008875_abnormal_xenobiotic_pharmacok | 1.76791446 |
| 39 | MP0001970_abnormal_pain_threshold | 1.75643869 |
| 40 | MP0002837_dystrophic_cardiac_calcinosis | 1.71088660 |
| 41 | MP0005365_abnormal_bile_salt | 1.69437802 |
| 42 | MP0003137_abnormal_impulse_conducting | 1.64843903 |
| 43 | MP0003172_abnormal_lysosome_physiology | 1.64803103 |
| 44 | MP0009780_abnormal_chondrocyte_physiolo | 1.63569804 |
| 45 | MP0005386_behavior/neurological_phenoty | 1.61792900 |
| 46 | MP0004924_abnormal_behavior | 1.61792900 |
| 47 | MP0001440_abnormal_grooming_behavior | 1.61052677 |
| 48 | MP0003646_muscle_fatigue | 1.56705280 |
| 49 | MP0006035_abnormal_mitochondrial_morpho | 1.54118610 |
| 50 | MP0003136_yellow_coat_color | 1.53682540 |
| 51 | MP0004858_abnormal_nervous_system | 1.52692829 |
| 52 | MP0002067_abnormal_sensory_capabilities | 1.50385592 |
| 53 | MP0002557_abnormal_social/conspecific_i | 1.47700908 |
| 54 | MP0006276_abnormal_autonomic_nervous | 1.46969418 |
| 55 | MP0003879_abnormal_hair_cell | 1.44667993 |
| 56 | MP0004811_abnormal_neuron_physiology | 1.42668410 |
| 57 | MP0005334_abnormal_fat_pad | 1.42140049 |
| 58 | MP0004885_abnormal_endolymph | 1.40373263 |
| 59 | MP0002102_abnormal_ear_morphology | 1.38765464 |
| 60 | MP0010234_abnormal_vibrissa_follicle | 1.36996055 |
| 61 | MP0008872_abnormal_physiological_respon | 1.36917673 |
| 62 | MP0003718_maternal_effect | 1.36858491 |
| 63 | MP0009384_cardiac_valve_regurgitation | 1.35265436 |
| 64 | MP0002184_abnormal_innervation | 1.34780923 |
| 65 | MP0003633_abnormal_nervous_system | 1.33480382 |
| 66 | MP0008569_lethality_at_weaning | 1.32947952 |
| 67 | MP0008874_decreased_physiological_sensi | 1.31537265 |
| 68 | MP0003186_abnormal_redox_activity | 1.31332712 |
| 69 | MP0005535_abnormal_body_temperature | 1.25637041 |
| 70 | MP0003075_altered_response_to | 1.25602430 |
| 71 | MP0005332_abnormal_amino_acid | 1.20529549 |
| 72 | MP0002066_abnormal_motor_capabilities/c | 1.20238768 |
| 73 | MP0010329_abnormal_lipoprotein_level | 1.19090443 |
| 74 | MP0003950_abnormal_plasma_membrane | 1.17604703 |
| 75 | MP0000427_abnormal_hair_cycle | 1.17387960 |
| 76 | MP0000955_abnormal_spinal_cord | 1.16050289 |
| 77 | MP0003252_abnormal_bile_duct | 1.13836821 |
| 78 | MP0001905_abnormal_dopamine_level | 1.10320840 |
| 79 | MP0004510_myositis | 1.09909658 |
| 80 | MP0000778_abnormal_nervous_system | 1.08286141 |
| 81 | MP0003195_calcinosis | 1.06650041 |
| 82 | MP0008961_abnormal_basal_metabolism | 1.06537968 |
| 83 | MP0002882_abnormal_neuron_morphology | 1.05851884 |
| 84 | MP0000604_amyloidosis | 1.05354946 |
| 85 | MP0003631_nervous_system_phenotype | 1.05224714 |
| 86 | MP0004043_abnormal_pH_regulation | 1.02512681 |
| 87 | MP0002069_abnormal_eating/drinking_beha | 1.02089285 |
| 88 | MP0002282_abnormal_trachea_morphology | 1.01845890 |
| 89 | MP0003935_abnormal_craniofacial_develop | 1.00632237 |
| 90 | MP0005167_abnormal_blood-brain_barrier | 1.00103578 |
| 91 | MP0003690_abnormal_glial_cell | 0.99399907 |
| 92 | MP0002234_abnormal_pharynx_morphology | 0.98806306 |
| 93 | MP0005645_abnormal_hypothalamus_physiol | 0.98765676 |
| 94 | MP0001502_abnormal_circadian_rhythm | 0.98029149 |
| 95 | MP0001177_atelectasis | 0.96585984 |
| 96 | MP0000013_abnormal_adipose_tissue | 0.93612684 |
| 97 | MP0002751_abnormal_autonomic_nervous | 0.91684749 |
| 98 | MP0000653_abnormal_sex_gland | 0.91148523 |
| 99 | MP0004142_abnormal_muscle_tone | 0.89942164 |
| 100 | MP0005391_vision/eye_phenotype | 0.88862784 |
| 101 | MP0004264_abnormal_extraembryonic_tissu | 0.85764378 |
| 102 | MP0005394_taste/olfaction_phenotype | 0.85629417 |
| 103 | MP0005499_abnormal_olfactory_system | 0.85629417 |
| 104 | MP0005410_abnormal_fertilization | 0.84675396 |
| 105 | MP0004133_heterotaxia | 0.83731361 |
| 106 | MP0002229_neurodegeneration | 0.82520523 |
| 107 | MP0000749_muscle_degeneration | 0.82478442 |
| 108 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.82262011 |
| 109 | MP0005174_abnormal_tail_pigmentation | 0.81026473 |
| 110 | MP0004085_abnormal_heartbeat | 0.80904038 |
| 111 | MP0005083_abnormal_biliary_tract | 0.80519808 |
| 112 | MP0001765_abnormal_ion_homeostasis | 0.80463389 |
| 113 | MP0000383_abnormal_hair_follicle | 0.80359817 |
| 114 | MP0001730_embryonic_growth_arrest | 0.79645313 |
| 115 | MP0002075_abnormal_coat/hair_pigmentati | 0.79452752 |
| 116 | MP0002876_abnormal_thyroid_physiology | 0.79157170 |
| 117 | MP0001666_abnormal_nutrient_absorption | 0.78393454 |
| 118 | MP0010386_abnormal_urinary_bladder | 0.77437888 |
| 119 | MP0002090_abnormal_vision | 0.77319509 |
| 120 | MP0002693_abnormal_pancreas_physiology | 0.77055244 |
| 121 | MP0002152_abnormal_brain_morphology | 0.77004635 |
| 122 | MP0004019_abnormal_vitamin_homeostasis | 0.76355665 |
| 123 | MP0008877_abnormal_DNA_methylation | 0.75521347 |
| 124 | MP0000751_myopathy | 0.74412655 |
| 125 | MP0002118_abnormal_lipid_homeostasis | 0.73759438 |
| 126 | MP0004381_abnormal_hair_follicle | 0.73444499 |
| 127 | MP0002084_abnormal_developmental_patter | 0.73139804 |
| 128 | MP0000920_abnormal_myelination | 0.72595101 |
| 129 | MP0004742_abnormal_vestibular_system | 0.71703694 |
| 130 | MP0005310_abnormal_salivary_gland | 0.71528077 |
| 131 | MP0009250_abnormal_appendicular_skeleto | 0.70973492 |
| 132 | MP0005636_abnormal_mineral_homeostasis | 0.69718444 |
| 133 | MP0002210_abnormal_sex_determination | 0.68385336 |
| 134 | MP0000631_abnormal_neuroendocrine_gland | 0.68379970 |
| 135 | MP0001145_abnormal_male_reproductive | 0.67816723 |
| 136 | MP0005084_abnormal_gallbladder_morpholo | 0.67815650 |
| 137 | MP0008770_decreased_survivor_rate | 0.67665282 |
| 138 | MP0000428_abnormal_craniofacial_morphol | 0.67372582 |
| 139 | MP0003283_abnormal_digestive_organ | 0.67251958 |
| 140 | MP0005075_abnormal_melanosome_morpholog | 0.66584870 |
| 141 | MP0001764_abnormal_homeostasis | 0.66162579 |
| 142 | MP0002161_abnormal_fertility/fecundity | 0.65541593 |
| 143 | MP0002163_abnormal_gland_morphology | 0.65365903 |
| 144 | MP0003936_abnormal_reproductive_system | 0.64337441 |
| 145 | MP0005409_darkened_coat_color | 0.64271695 |
| 146 | MP0002752_abnormal_somatic_nervous | 0.63990873 |
| 147 | MP0005620_abnormal_muscle_contractility | 0.63523984 |
| 148 | MP0005166_decreased_susceptibility_to | 0.63318543 |
| 149 | MP0005551_abnormal_eye_electrophysiolog | 0.60615218 |
| 150 | MP0003634_abnormal_glial_cell | 0.60382369 |
| 151 | MP0001963_abnormal_hearing_physiology | 0.59730244 |
| 152 | MP0003632_abnormal_nervous_system | 0.58000146 |
| 153 | MP0003868_abnormal_feces_composition | 0.57116341 |
| 154 | MP0000026_abnormal_inner_ear | 0.57115811 |
| 155 | MP0001119_abnormal_female_reproductive | 0.56995048 |
| 156 | MP0001485_abnormal_pinna_reflex | 0.56977684 |
| 157 | MP0006292_abnormal_olfactory_placode | 0.56633230 |
| 158 | MP0001324_abnormal_eye_pigmentation | 0.56153730 |
| 159 | MP0001756_abnormal_urination | 0.55545766 |
| 160 | MP0001664_abnormal_digestion | 0.54136362 |
| 161 | MP0000230_abnormal_systemic_arterial | 0.53908925 |
| 162 | MP0004130_abnormal_muscle_cell | 0.52358668 |
| 163 | MP0002078_abnormal_glucose_homeostasis | 0.49350913 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 7.80877665 |
| 2 | Prostate neoplasm (HP:0100787) | 7.37346959 |
| 3 | Focal motor seizures (HP:0011153) | 6.26033433 |
| 4 | Pendular nystagmus (HP:0012043) | 6.00727905 |
| 5 | Abnormality of the hepatic vasculature (HP:0006707) | 5.39647309 |
| 6 | Slow saccadic eye movements (HP:0000514) | 5.25548108 |
| 7 | Focal seizures (HP:0007359) | 4.93170923 |
| 8 | Postural tremor (HP:0002174) | 4.84037218 |
| 9 | Limb ataxia (HP:0002070) | 4.18908177 |
| 10 | Torticollis (HP:0000473) | 4.06828089 |
| 11 | Severe visual impairment (HP:0001141) | 4.06322178 |
| 12 | Hypochromic microcytic anemia (HP:0004840) | 3.99501005 |
| 13 | Action tremor (HP:0002345) | 3.79715665 |
| 14 | Visual hallucinations (HP:0002367) | 3.75087324 |
| 15 | Focal dystonia (HP:0004373) | 3.66571412 |
| 16 | Craniofacial dystonia (HP:0012179) | 3.66155772 |
| 17 | Abnormality of the prostate (HP:0008775) | 3.55752162 |
| 18 | Generalized tonic-clonic seizures (HP:0002069) | 3.48618940 |
| 19 | Impaired proprioception (HP:0010831) | 3.44241591 |
| 20 | Abnormality of macular pigmentation (HP:0008002) | 3.41878761 |
| 21 | Absence seizures (HP:0002121) | 3.37802102 |
| 22 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.37429473 |
| 23 | Anxiety (HP:0000739) | 3.33063613 |
| 24 | Epileptic encephalopathy (HP:0200134) | 3.28561124 |
| 25 | Poor eye contact (HP:0000817) | 3.27481374 |
| 26 | Atonic seizures (HP:0010819) | 3.25539996 |
| 27 | Febrile seizures (HP:0002373) | 3.15696038 |
| 28 | Ankle clonus (HP:0011448) | 3.13844086 |
| 29 | Abnormal social behavior (HP:0012433) | 3.12253331 |
| 30 | Impaired social interactions (HP:0000735) | 3.12253331 |
| 31 | Dialeptic seizures (HP:0011146) | 3.10048328 |
| 32 | Increased corneal curvature (HP:0100692) | 3.07402150 |
| 33 | Keratoconus (HP:0000563) | 3.07402150 |
| 34 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.05641445 |
| 35 | Hyperventilation (HP:0002883) | 3.01450933 |
| 36 | Depression (HP:0000716) | 2.93824237 |
| 37 | Status epilepticus (HP:0002133) | 2.93649468 |
| 38 | Resting tremor (HP:0002322) | 2.92354825 |
| 39 | Bilateral microphthalmos (HP:0007633) | 2.91249925 |
| 40 | Postnatal microcephaly (HP:0005484) | 2.88466669 |
| 41 | Gout (HP:0001997) | 2.87238081 |
| 42 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.86052069 |
| 43 | Dysdiadochokinesis (HP:0002075) | 2.85987599 |
| 44 | Annular pancreas (HP:0001734) | 2.84538475 |
| 45 | Deep venous thrombosis (HP:0002625) | 2.81987135 |
| 46 | Abnormality of the lower motor neuron (HP:0002366) | 2.80845691 |
| 47 | Urinary urgency (HP:0000012) | 2.80302766 |
| 48 | Abnormal eating behavior (HP:0100738) | 2.80077318 |
| 49 | Termporal pattern (HP:0011008) | 2.78646122 |
| 50 | Insidious onset (HP:0003587) | 2.78646122 |
| 51 | Rib fusion (HP:0000902) | 2.75259888 |
| 52 | Postural instability (HP:0002172) | 2.75236210 |
| 53 | Supranuclear gaze palsy (HP:0000605) | 2.74615486 |
| 54 | Dysmetria (HP:0001310) | 2.74410423 |
| 55 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.72607208 |
| 56 | Areflexia of lower limbs (HP:0002522) | 2.67711351 |
| 57 | Broad-based gait (HP:0002136) | 2.67329232 |
| 58 | Vitreoretinal degeneration (HP:0000655) | 2.62332004 |
| 59 | Delayed CNS myelination (HP:0002188) | 2.60847434 |
| 60 | Progressive cerebellar ataxia (HP:0002073) | 2.56806991 |
| 61 | Gaze-evoked nystagmus (HP:0000640) | 2.53043749 |
| 62 | Neurofibrillary tangles (HP:0002185) | 2.46173622 |
| 63 | Scanning speech (HP:0002168) | 2.45733923 |
| 64 | Impaired vibratory sensation (HP:0002495) | 2.44995945 |
| 65 | Chorioretinal atrophy (HP:0000533) | 2.44233881 |
| 66 | Intention tremor (HP:0002080) | 2.44056879 |
| 67 | Amblyopia (HP:0000646) | 2.44044510 |
| 68 | Abnormality of vision evoked potentials (HP:0000649) | 2.43720007 |
| 69 | Spastic gait (HP:0002064) | 2.34917240 |
| 70 | Decreased muscle mass (HP:0003199) | 2.33255247 |
| 71 | Cerebral inclusion bodies (HP:0100314) | 2.33191647 |
| 72 | Papilledema (HP:0001085) | 2.31601675 |
| 73 | Xanthomatosis (HP:0000991) | 2.31264011 |
| 74 | Dysmetric saccades (HP:0000641) | 2.29817592 |
| 75 | Bradykinesia (HP:0002067) | 2.26958952 |
| 76 | Abnormality of saccadic eye movements (HP:0000570) | 2.26158996 |
| 77 | Neonatal onset (HP:0003623) | 2.25624659 |
| 78 | Sensorimotor neuropathy (HP:0007141) | 2.24017505 |
| 79 | Clumsiness (HP:0002312) | 2.23647872 |
| 80 | Severe Myopia (HP:0011003) | 2.22483678 |
| 81 | Stereotypic behavior (HP:0000733) | 2.20993359 |
| 82 | Decreased central vision (HP:0007663) | 2.20958095 |
| 83 | Ketosis (HP:0001946) | 2.20632384 |
| 84 | Limb dystonia (HP:0002451) | 2.20118245 |
| 85 | Biliary tract neoplasm (HP:0100574) | 2.17879931 |
| 86 | Clonus (HP:0002169) | 2.12737829 |
| 87 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.11928149 |
| 88 | Truncal ataxia (HP:0002078) | 2.11844535 |
| 89 | Intrahepatic cholestasis (HP:0001406) | 2.11723413 |
| 90 | Oculomotor apraxia (HP:0000657) | 2.10499379 |
| 91 | Abolished electroretinogram (ERG) (HP:0000550) | 2.09996019 |
| 92 | Epileptiform EEG discharges (HP:0011182) | 2.08968511 |
| 93 | EEG with generalized epileptiform discharges (HP:0011198) | 2.08809128 |
| 94 | Retinitis pigmentosa (HP:0000510) | 2.08424463 |
| 95 | Proximal tubulopathy (HP:0000114) | 2.04912761 |
| 96 | Hypochromic anemia (HP:0001931) | 2.04483065 |
| 97 | Abnormality of male internal genitalia (HP:0000022) | 2.03597797 |
| 98 | Increased circulating renin level (HP:0000848) | 2.03514659 |
| 99 | Impaired pain sensation (HP:0007328) | 2.00587353 |
| 100 | Abnormality of pain sensation (HP:0010832) | 2.00587353 |
| 101 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.00235945 |
| 102 | Genetic anticipation (HP:0003743) | 11.1964878 |
| 103 | Hyperglycinemia (HP:0002154) | 1.99899593 |
| 104 | Hypsarrhythmia (HP:0002521) | 1.99512608 |
| 105 | Ankyloglossia (HP:0010296) | 1.99231195 |
| 106 | Ketoacidosis (HP:0001993) | 1.97364582 |
| 107 | Hyperlipoproteinemia (HP:0010980) | 1.96521896 |
| 108 | Axonal loss (HP:0003447) | 1.96496285 |
| 109 | Mutism (HP:0002300) | 1.96287574 |
| 110 | Protruding tongue (HP:0010808) | 1.96142789 |
| 111 | Pheochromocytoma (HP:0002666) | 1.95938529 |
| 112 | Fair hair (HP:0002286) | 1.92230197 |
| 113 | Lower limb muscle weakness (HP:0007340) | 1.91867518 |
| 114 | Generalized myoclonic seizures (HP:0002123) | 1.91814859 |
| 115 | Hypobetalipoproteinemia (HP:0003563) | 1.89625267 |
| 116 | Ventricular fibrillation (HP:0001663) | 1.88437249 |
| 117 | Hammertoe (HP:0001765) | 1.88427640 |
| 118 | Abnormality of the corticospinal tract (HP:0002492) | 1.88255311 |
| 119 | Abnormal gallbladder physiology (HP:0012438) | 1.88246110 |
| 120 | Cholecystitis (HP:0001082) | 1.88246110 |
| 121 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.87319759 |
| 122 | Lower limb asymmetry (HP:0100559) | 1.86664960 |
| 123 | Megalencephaly (HP:0001355) | 1.86492251 |
| 124 | Tetraplegia (HP:0002445) | 1.86050142 |
| 125 | Anomalous pulmonary venous return (HP:0010772) | 1.85943341 |
| 126 | Hypoplasia of the fovea (HP:0007750) | 1.85415201 |
| 127 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.85415201 |
| 128 | Hemiparesis (HP:0001269) | 1.82168568 |
| 129 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.81998946 |
| 130 | Abnormality of glycine metabolism (HP:0010895) | 1.81998946 |
| 131 | Polygenic inheritance (HP:0010982) | 1.81841911 |
| 132 | Prolonged QT interval (HP:0001657) | 1.81684037 |
| 133 | Portal hypertension (HP:0001409) | 1.80913665 |
| 134 | Pointed chin (HP:0000307) | 1.80849555 |
| 135 | Onion bulb formation (HP:0003383) | 1.80408591 |
| 136 | Hyperglycinuria (HP:0003108) | 1.80268884 |
| 137 | Impaired smooth pursuit (HP:0007772) | 1.80232451 |
| 138 | Incomplete penetrance (HP:0003829) | 1.79051481 |
| 139 | Blue irides (HP:0000635) | 1.78560218 |
| 140 | Hemiplegia (HP:0002301) | 1.77143969 |
| 141 | Chromsome breakage (HP:0040012) | 1.76351088 |
| 142 | Hyperammonemia (HP:0001987) | 1.76137172 |
| 143 | Rigidity (HP:0002063) | 1.75893533 |
| 144 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.75740402 |
| 145 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.71441149 |
| 146 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.70444197 |
| 147 | True hermaphroditism (HP:0010459) | 1.69015673 |
| 148 | Fused cervical vertebrae (HP:0002949) | 1.68267976 |
| 149 | Pancreatic cysts (HP:0001737) | 1.67526747 |
| 150 | Inability to walk (HP:0002540) | 1.67305100 |
| 151 | Facial diplegia (HP:0001349) | 1.65559856 |
| 152 | Absent/shortened dynein arms (HP:0200106) | 1.63126376 |
| 153 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.63126376 |
| 154 | Abnormality of the fovea (HP:0000493) | 1.63027067 |
| 155 | Loss of speech (HP:0002371) | 1.62915844 |
| 156 | Abnormality of the pulmonary veins (HP:0011718) | 1.61313015 |
| 157 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.56486421 |
| 158 | Generalized aminoaciduria (HP:0002909) | 1.56483423 |
| 159 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.56089465 |
| 160 | Tinnitus (HP:0000360) | 1.55902691 |
| 161 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.55442845 |
| 162 | Absent speech (HP:0001344) | 1.54981678 |
| 163 | Amaurosis fugax (HP:0100576) | 1.52836548 |
| 164 | Congenital stationary night blindness (HP:0007642) | 1.52248628 |
| 165 | Attenuation of retinal blood vessels (HP:0007843) | 1.51734680 |
| 166 | Macular degeneration (HP:0000608) | 1.50209536 |
| 167 | Ectopic kidney (HP:0000086) | 1.48711601 |
| 168 | Fasciculations (HP:0002380) | 1.47145790 |
| 169 | Pancreatic fibrosis (HP:0100732) | 1.46669433 |
| 170 | Scrotal hypoplasia (HP:0000046) | 1.44507287 |
| 171 | Hyperthyroidism (HP:0000836) | 1.43694111 |
| 172 | Gingival bleeding (HP:0000225) | 1.42698172 |
| 173 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.41173290 |
| 174 | Increased density of long bones (HP:0006392) | 1.40283132 |
| 175 | Exotropia (HP:0000577) | 1.38699565 |
| 176 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.38386935 |
| 177 | Abnormal ciliary motility (HP:0012262) | 1.37559822 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 6.12522308 |
| 2 | FRK | 5.22694231 |
| 3 | MAP3K9 | 4.14686425 |
| 4 | NTRK3 | 3.77858170 |
| 5 | ACVR1B | 3.03909757 |
| 6 | KSR2 | 3.01236040 |
| 7 | DAPK2 | 2.99483982 |
| 8 | ARAF | 2.73617181 |
| 9 | BMPR1B | 2.46946361 |
| 10 | MAP3K4 | 2.40736890 |
| 11 | MINK1 | 2.33673529 |
| 12 | MAP3K13 | 2.23603046 |
| 13 | NTRK1 | 2.21405884 |
| 14 | PRKD3 | 2.18567381 |
| 15 | GRK1 | 2.10094606 |
| 16 | RIPK4 | 2.03702694 |
| 17 | MKNK2 | 2.02831676 |
| 18 | PAK6 | 1.98875031 |
| 19 | CAMKK1 | 1.90325674 |
| 20 | KSR1 | 1.84698527 |
| 21 | MAP2K4 | 1.83731435 |
| 22 | MAP2K7 | 1.79194970 |
| 23 | MARK1 | 1.72005848 |
| 24 | NTRK2 | 1.52021622 |
| 25 | SIK2 | 1.49893533 |
| 26 | TXK | 1.46075309 |
| 27 | DAPK1 | 1.45754124 |
| 28 | CDK5 | 1.45467969 |
| 29 | ADRBK2 | 1.42783455 |
| 30 | ZAK | 1.41883069 |
| 31 | STK38 | 1.40221684 |
| 32 | MAP3K2 | 1.38557574 |
| 33 | TAOK1 | 1.36370244 |
| 34 | SGK223 | 1.31070039 |
| 35 | SGK494 | 1.31070039 |
| 36 | PINK1 | 1.23829700 |
| 37 | MKNK1 | 1.23731991 |
| 38 | FES | 1.23335154 |
| 39 | MAP3K12 | 1.22147347 |
| 40 | RAF1 | 1.21038978 |
| 41 | PRPF4B | 1.16325318 |
| 42 | RPS6KB2 | 1.15858105 |
| 43 | BMPR2 | 1.14449788 |
| 44 | OXSR1 | 1.10625951 |
| 45 | CAMKK2 | 1.06869541 |
| 46 | TGFBR1 | 1.06204114 |
| 47 | TYRO3 | 1.03354609 |
| 48 | SGK2 | 1.03219233 |
| 49 | GRK5 | 0.99650241 |
| 50 | PRKCG | 0.97877586 |
| 51 | WNK3 | 0.95980169 |
| 52 | STK3 | 0.94939715 |
| 53 | RET | 0.92726637 |
| 54 | SGK3 | 0.91204092 |
| 55 | PLK4 | 0.90055319 |
| 56 | INSRR | 0.88759237 |
| 57 | PRKCH | 0.87967516 |
| 58 | MAPK13 | 0.86858558 |
| 59 | BCR | 0.86805155 |
| 60 | BRAF | 0.85948227 |
| 61 | TAF1 | 0.84749853 |
| 62 | NEK1 | 0.83875159 |
| 63 | WNK4 | 0.82724090 |
| 64 | MAP3K1 | 0.82560977 |
| 65 | PDPK1 | 0.82540906 |
| 66 | TNIK | 0.79524616 |
| 67 | LATS2 | 0.76633429 |
| 68 | CDK18 | 0.76374772 |
| 69 | CAMK2A | 0.76138974 |
| 70 | MAP2K1 | 0.73870600 |
| 71 | CDK15 | 0.73401244 |
| 72 | STK11 | 0.73331467 |
| 73 | PHKG1 | 0.73240166 |
| 74 | PHKG2 | 0.73240166 |
| 75 | PTK2B | 0.72850250 |
| 76 | STK38L | 0.72453319 |
| 77 | CDK14 | 0.71947024 |
| 78 | PDK1 | 0.71637865 |
| 79 | LMTK2 | 0.71422425 |
| 80 | UHMK1 | 0.71125913 |
| 81 | SGK1 | 0.70705687 |
| 82 | TNK2 | 0.67378710 |
| 83 | PRKCZ | 0.66773095 |
| 84 | CAMK2B | 0.65671279 |
| 85 | RIPK1 | 0.65572358 |
| 86 | PBK | 0.64369958 |
| 87 | MOS | 0.63823699 |
| 88 | PLK2 | 0.62474971 |
| 89 | CAMK1 | 0.62146087 |
| 90 | CDK11A | 0.60687883 |
| 91 | OBSCN | 0.60638113 |
| 92 | CHEK2 | 0.60286142 |
| 93 | PAK3 | 0.59620927 |
| 94 | MARK2 | 0.59122566 |
| 95 | SIK3 | 0.54853374 |
| 96 | CSNK1G2 | 0.53175566 |
| 97 | CAMK2G | 0.51331922 |
| 98 | MATK | 0.50680474 |
| 99 | MAPKAPK5 | 0.50115875 |
| 100 | VRK2 | 0.48828557 |
| 101 | CAMK4 | 0.47918925 |
| 102 | ADRBK1 | 0.47142496 |
| 103 | MAP3K7 | 0.46856526 |
| 104 | RPS6KA3 | 0.46488824 |
| 105 | DAPK3 | 0.44371364 |
| 106 | CHEK1 | 0.44120658 |
| 107 | CDK19 | 0.43565010 |
| 108 | CASK | 0.43483639 |
| 109 | DYRK2 | 0.41844081 |
| 110 | JAK2 | 0.41692465 |
| 111 | CDK4 | 0.40790393 |
| 112 | CCNB1 | 0.39974967 |
| 113 | FER | 0.39279100 |
| 114 | PRKAA2 | 0.37626724 |
| 115 | FYN | 0.36949690 |
| 116 | TIE1 | 0.36192249 |
| 117 | NEK6 | 0.36038856 |
| 118 | PRKD2 | 0.35508951 |
| 119 | FGFR2 | 0.35044532 |
| 120 | ALK | 0.34255506 |
| 121 | WNK1 | 0.34108661 |
| 122 | STK39 | 0.34030563 |
| 123 | DYRK1A | 0.33860286 |
| 124 | MAPK10 | 0.33760629 |
| 125 | PRKACG | 0.33496907 |
| 126 | BCKDK | 0.33369048 |
| 127 | PRKCE | 0.32815208 |
| 128 | PRKG1 | 0.32294673 |
| 129 | NUAK1 | 0.31220691 |
| 130 | PRKCB | 0.29949937 |
| 131 | PNCK | 0.29776772 |
| 132 | MAP3K6 | 0.29727623 |
| 133 | CAMK2D | 0.29695351 |
| 134 | TTK | 0.28564413 |
| 135 | MAP4K2 | 0.28556141 |
| 136 | MAPK7 | 0.27390041 |
| 137 | PKN1 | 0.27252085 |
| 138 | CSNK1G1 | 0.26789235 |
| 139 | VRK1 | 0.26061400 |
| 140 | RPS6KB1 | 0.24161813 |
| 141 | MTOR | 0.23322413 |
| 142 | AURKA | 0.22944610 |
| 143 | TAOK3 | 0.22075007 |
| 144 | ERBB2 | 0.19802314 |
| 145 | GRK7 | 0.18777089 |
| 146 | PDGFRA | 0.18121222 |
| 147 | PRKACA | 0.16909885 |
| 148 | ERBB4 | 0.14920703 |
| 149 | CSNK1A1 | 0.14535876 |
| 150 | PRKAA1 | 0.14310980 |
| 151 | CSNK1G3 | 0.12870507 |
| 152 | PRKCA | 0.11992105 |
| 153 | PRKACB | 0.10476471 |
| 154 | CDK9 | 0.10056148 |
| 155 | MELK | 0.09481592 |
| 156 | CSNK1D | 0.09026445 |
| 157 | CSNK1A1L | 0.08637568 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 3.41709939 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.23599354 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 3.17663044 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.61821043 |
| 5 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.40026578 |
| 6 | Nicotine addiction_Homo sapiens_hsa05033 | 2.38360897 |
| 7 | RNA polymerase_Homo sapiens_hsa03020 | 2.36486421 |
| 8 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.28317779 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.27925256 |
| 10 | GABAergic synapse_Homo sapiens_hsa04727 | 2.27763171 |
| 11 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.20994013 |
| 12 | Morphine addiction_Homo sapiens_hsa05032 | 2.14040340 |
| 13 | Circadian entrainment_Homo sapiens_hsa04713 | 2.13630859 |
| 14 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.06491168 |
| 15 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.05010138 |
| 16 | Retinol metabolism_Homo sapiens_hsa00830 | 2.04797425 |
| 17 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.99834304 |
| 18 | Long-term potentiation_Homo sapiens_hsa04720 | 1.97069723 |
| 19 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.94327803 |
| 20 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.89909655 |
| 21 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.87010068 |
| 22 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.85197672 |
| 23 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.84481453 |
| 24 | Cocaine addiction_Homo sapiens_hsa05030 | 1.79702144 |
| 25 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.74691588 |
| 26 | Salivary secretion_Homo sapiens_hsa04970 | 1.68491384 |
| 27 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.62351160 |
| 28 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.59498489 |
| 29 | Bile secretion_Homo sapiens_hsa04976 | 1.53182196 |
| 30 | Insulin secretion_Homo sapiens_hsa04911 | 1.53170089 |
| 31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.48929285 |
| 32 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.48793767 |
| 33 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.46715339 |
| 34 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.45929337 |
| 35 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.44570493 |
| 36 | Renin secretion_Homo sapiens_hsa04924 | 1.42511962 |
| 37 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.33709185 |
| 38 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.31006083 |
| 39 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.26754469 |
| 40 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.25901893 |
| 41 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.23162441 |
| 42 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.21002096 |
| 43 | Taste transduction_Homo sapiens_hsa04742 | 1.20775066 |
| 44 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.20330499 |
| 45 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.19028709 |
| 46 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.17284168 |
| 47 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.13375386 |
| 48 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.12870441 |
| 49 | Gap junction_Homo sapiens_hsa04540 | 1.10066921 |
| 50 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.09428444 |
| 51 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.06112254 |
| 52 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.04633881 |
| 53 | Purine metabolism_Homo sapiens_hsa00230 | 1.01214759 |
| 54 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.01078974 |
| 55 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.00839802 |
| 56 | Long-term depression_Homo sapiens_hsa04730 | 1.00630735 |
| 57 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.97602264 |
| 58 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.97065737 |
| 59 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.93933850 |
| 60 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.93340014 |
| 61 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.91335648 |
| 62 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.86574598 |
| 63 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.86013788 |
| 64 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.83209773 |
| 65 | Glioma_Homo sapiens_hsa05214 | 0.79395010 |
| 66 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.78769399 |
| 67 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.74396540 |
| 68 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.73769686 |
| 69 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.73532612 |
| 70 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.73296823 |
| 71 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.72584405 |
| 72 | Homologous recombination_Homo sapiens_hsa03440 | 0.72061935 |
| 73 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.69123127 |
| 74 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.68995717 |
| 75 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.68840398 |
| 76 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.68470564 |
| 77 | Circadian rhythm_Homo sapiens_hsa04710 | 0.67998812 |
| 78 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.67958750 |
| 79 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.67634846 |
| 80 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.66792338 |
| 81 | Melanogenesis_Homo sapiens_hsa04916 | 0.66742894 |
| 82 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.66585933 |
| 83 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.65973915 |
| 84 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.65389516 |
| 85 | ABC transporters_Homo sapiens_hsa02010 | 0.64838489 |
| 86 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.64121722 |
| 87 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.63011425 |
| 88 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.62074027 |
| 89 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.61727186 |
| 90 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.61472800 |
| 91 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.60978312 |
| 92 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.59973141 |
| 93 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.59636841 |
| 94 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.58971181 |
| 95 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.57348940 |
| 96 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.56953842 |
| 97 | Peroxisome_Homo sapiens_hsa04146 | 0.56032994 |
| 98 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.55764376 |
| 99 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.55226179 |
| 100 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54617571 |
| 101 | Prion diseases_Homo sapiens_hsa05020 | 0.54392786 |
| 102 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.52983350 |
| 103 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.52865759 |
| 104 | Axon guidance_Homo sapiens_hsa04360 | 0.51083880 |
| 105 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.50594103 |
| 106 | Melanoma_Homo sapiens_hsa05218 | 0.50340318 |
| 107 | Phototransduction_Homo sapiens_hsa04744 | 0.49774860 |
| 108 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.47970392 |
| 109 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.47830569 |
| 110 | Histidine metabolism_Homo sapiens_hsa00340 | 0.46049575 |
| 111 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.45943444 |
| 112 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.44780555 |
| 113 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.44382898 |
| 114 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.43962514 |
| 115 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.42364361 |
| 116 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.41699861 |
| 117 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.40884568 |
| 118 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.39206367 |
| 119 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.38814752 |
| 120 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.38447915 |
| 121 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.38348945 |
| 122 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.38197543 |
| 123 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.36688242 |
| 124 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.35844741 |
| 125 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.35142747 |
| 126 | Alcoholism_Homo sapiens_hsa05034 | 0.34876732 |
| 127 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.34238104 |
| 128 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.34209911 |
| 129 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.34163328 |
| 130 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.34022938 |
| 131 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.33974374 |
| 132 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.33607124 |
| 133 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.32827671 |
| 134 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.32825082 |
| 135 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.28480777 |
| 136 | Metabolic pathways_Homo sapiens_hsa01100 | 0.28247498 |
| 137 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.28243535 |
| 138 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.28046281 |
| 139 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.26854007 |
| 140 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.26798388 |
| 141 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.26691479 |
| 142 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.25018248 |
| 143 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.23881388 |
| 144 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.21722576 |

